We are live on
!
Find out more
VT
Vise Technologies Portfolio holdings
AUM
$5.09B
1-Year Est. Return
22.62%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+22.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
FYBR
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.38% |
| 2 | Financials | 8.06% |
| 3 | Consumer Discretionary | 4.74% |
| 4 | Communication Services | 4.49% |
| 5 | Healthcare | 4.02% |
Similar funds
NC
CS
CTC
EIC
AC
CIA
TAM
JIM
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.